Maxcyte (MXCT) Gross Margin Growth (1y) (2021 - 2026)
Maxcyte (MXCT) Gross Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -67.00 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -54.00 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -265.00 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 62.00 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -65.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.00 |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 610.00 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -359.00 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 58.00 |
| 10 | Maxcyte | 127.72 Mn | 127.72 Mn | 8.08 Mn | -7,111.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,111.00 |
| Dec 31, 2025 | -19,307.00 |
| Sep 30, 2025 | 24.00 |
| Jun 30, 2025 | -6,013.00 |
| Mar 31, 2025 | -2,314.00 |
| Dec 31, 2024 | -22,254.00 |
| Sep 30, 2024 | -9,712.00 |
| Jun 30, 2024 | 9,533.00 |
| Mar 31, 2024 | 2,537.00 |
| Dec 31, 2023 | 64,832.00 |
| Sep 30, 2023 | 4,385.00 |
| Jun 30, 2023 | -355.00 |
| Mar 31, 2023 | 6,179.00 |
| Dec 31, 2022 | 5,919.00 |
| Sep 30, 2022 | -3,429.00 |
| Jun 30, 2022 | -62.00 |
| Mar 31, 2022 | -4,604.00 |
| Dec 31, 2021 | -6,596.00 |
| Sep 30, 2021 | 3,485.00 |
| Jun 30, 2021 | -11,239.00 |